Breaking Health News: From Mpox to Cannabis Research

Recent health news covers various topics: a new mpox case in New York, promising results of Ozempic for alcohol use disorder, U.S. impact on global health funding, Robert F. Kennedy Jr.'s health nomination, innovative prostate cancer treatments, Brazil's cannabis cultivation research, Ventas' financial success, a new FDA-approved drug, and MediWound's trial initiation.

Breaking Health News: From Mpox to Cannabis Research

The Centers for Disease Control and Prevention confirmed a new mpox variant case in New York, isolating the patient while seeking contacts. Symptoms were improving without specific treatments.

Ozempic, a GLP-1 diabetes drug by Novo Nordisk, showed promise in reducing alcohol use disorder symptoms, according to a small trial.

The U.S. pause on foreign aid is impacting global health initiatives, said WHO Director-General Tedros Adhanom Ghebreyesus, urging the U.S. to reassess funding decisions.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.